Previous 10 | Next 10 |
home / stock / smgzy / smgzy news
Smiths Group plc (SMGKF) Q4 2022 Earnings Conference Call September 23, 2022 03:30 AM ET Company Participants Paul Keel - CEO Clare Scherrer - CFO Conference Call Participants Andrew Wilson - JPMorgan Andre Kukhnin - Credit Suisse Mark Davies Jone...
The following slide deck was published by Smiths Group plc in conjunction with their 2022 Q4 earnings call. For further details see: Smiths Group plc 2022 Q4 - Results - Earnings Call Presentation
ICU Medical has fallen well short of expectations for its first year with Smiths Medical in the fold, as the acquired operations have needed considerable work to address operational issues. Core ICU Medical operations are performing reasonably well, with mid-single-digit growth in the...
ICU Medical starts off 2022 with the considerable task of integrating Smiths Medical, a $2.35B deal that significantly expands ICUI's infusion business and adds complementary assets in other departments. In addition to leveraging even more scale, the Smiths deal gives ICU a more compe...
ICU Medical Completes the Acquisition of Smiths Medical from Smiths Group plc The addition of Smiths Medical syringe and ambulatory infusion devices, vascular access, and vital care products to the ICU Medical portfolio creates a leading infusion therapy company with a more robu...
Smiths Group plc (SMGKF) Q4 2021 Earnings Conference Call September 28, 2021 3:30 AM ET Company Participants Paul Keel - Chief Executive Officer John Shipsey - Chief Financial Officer Conference Call Participants Andy Wilson - JPMorgan Will Turner - Goldman Sachs Andre Kukhnin - Credit Suisse...
The following slide deck was published by Smiths Group plc in conjunction with their 2021 Q4 earnings call. For further details see: Smiths Group plc 2021 Q4 - Results - Earnings Call Presentation
Shares of ICU Medical (NASDAQ: ICUI) , a medical device company specializing in intravenous treatment solutions, were on the move today following the announcement of a cash and stock deal for Smiths Medical. The market signaled its approval of the pending acquisition by pushing the ...
The putative sale of Smiths' medical division brings focus. The price isn't great, but it will at least tidy up the group a little. The company looks expensive for its post-sale lineup of divisions. For that reason, I am bearish. For further details see: Smiths Group: Me...
Smiths Group plc (SMGKF) Q2 2021 Results Conference Call March 26, 2021 05:00 AM ET Company Participants Andy Reynolds Smith - CEO John Shipsey - CFO Conference Call Participants Andy Wilson - JPMorgan Mark Davies Jones - Stifel Andre Kukhnin - Credit Suisse Robert Davis - Morgan Stanley Chri...
News, Short Squeeze, Breakout and More Instantly...
Smiths Group Plc ADR Company Name:
SMGZY Stock Symbol:
OTCMKTS Market:
Kalera Public Limited Company (KALRQ) is expected to report for quarter end 2023-06-30 Humanigen Inc. (HGEN) is expected to report for Q2 2023 Ever-Glory International Group Inc. (EVKG) is expected to report for quarter end 2023-06-30 SunCar Technology Group Inc. (SDA) is expected to ...
Regenicin Inc (RGIN) is expected to report for quarter end 2023-06-30 Grasim Industries Ltd. ADR (GRSXY) is expected to report for quarter end 2023-06-30 Mitsubishi Heavy Industries Ltd. (MHVYF) is expected to report for Q1 2024 Japan Tobacco Inc. ADR (JAPAY) is expected to report $0....
Smiths Group plc ADR (SMGZY) is expected to report for Q4 2023